TYRA

TYRA

USD

Tyra Biosciences Inc. Common Stock

$15.000-0.210 (-1.381%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$15.210

Máximo

$15.720

Mínimo

$14.540

Volumen

0.09M

Fundamentos de la Empresa

Capitalización de Mercado

799.5M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

0.22M

Bolsa

NMS

Moneda

USD

Rango de 52 Semanas

Mínimo $6.42Actual $15.000Máximo $17.78

Noticias Relacionadas

Analyst Upgrades

Raymond James Initiates Coverage On Tyra Biosciences with Strong Buy Rating, Announces Price Target of $35

Raymond James analyst Chris Raymond initiates coverage on Tyra Biosciences with a Strong Buy rating and announces Price Target of $35.

Ver más
Raymond James Initiates Coverage On Tyra Biosciences with Strong Buy Rating, Announces Price Target of $35
Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Tyra Biosciences, Maintains $30 Price Target

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Tyra Biosciences with a Buy and maintains $30 price target.

Ver más
HC Wainwright & Co. Reiterates Buy on Tyra Biosciences, Maintains $30 Price Target
PR Newswire

Tyra Biosciences Announces First Child Dosed in BEACH301, its Phase 2 Study for Dabogratinib (TYRA-300) in Pediatric Achondroplasia

Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target...

Ver más
Tyra Biosciences Announces First Child Dosed in BEACH301, its Phase 2 Study for Dabogratinib (TYRA-300) in Pediatric Achondroplasia
PR Newswire

Tyra Biosciences Announces Participation at Upcoming Investor Events

Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target...

Ver más
Tyra Biosciences Announces Participation at Upcoming Investor Events